Back

Sep 30, 2016

Announcement of Cessation as Non-Executive Director (Lim Ee Seng)

Announcement Title Change - Announcement of Cessation
Announcement Subtitle Announcement of Cessation as Non-Executive Director
Securities FRASERS CENTREPOINT TRUST (FCT)
Date & Time of Broadcast Sep 30, 2016 18:47
Submitted By Piya Treruangrachada
Company Secretary
Description Announcement of Cessation as Non-Executive Director
Cessation Details
Name of person Lim Ee Seng
Age 65
Is effective date of cessation known? Yes
Effective date for cessation Oct 1, 2016
Detailed reason(s) for cessation Mr Lim's resignation from the Board of Frasers Centrepoint Asset Management Ltd. ("FCAM") is in line with his retirement as the Group Chief Executive Officer of Frasers Centrepoint Limited (the holding company of FCAM) on 1 October 2016.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting? No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer? No
Any other relevant information to be provided to shareholders of the listed issuer? No
Date of appointment to current position Jan 27, 2006
Does the AC have a minimum of 3 members (taking into account this cessation)? Yes
Number of independent directors currently resident in Singapore (taking this account this cessation) 3
Number of cessations of appointments specified in Listing Rule 704(7) or Catalist Rule 704(6) over the past 12 months 0
Job Title Non-Executive Director
Role and responsibilities As above
Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidaries No
Shareholdings interest in the listed issuer and its subsidaries? Yes
Shareholding Details 200,000 units in Frasers Centrepoint Trust
Other directorships
Past (for the last 5 years) Please see attachment
Present Please see attachment
Attachment 1

30 Sep 2016 | PDF 22,218 kb

Get in touch with our IR representative